首页> 外国专利> CONSERVED INNER CORE LIPOPOLYSACCHARIDE EPITOPES AS MULTI-SPECIES VACCINE CANDIDATES

CONSERVED INNER CORE LIPOPOLYSACCHARIDE EPITOPES AS MULTI-SPECIES VACCINE CANDIDATES

机译:保守的内脂寡糖表位作为多种疫苗的候选对象

摘要

A conserved inner-core oligosaccharide epitope expressed on the lipopolysaccharide (LPS) of a range of disease causing pathogenic bacterial isolates, including Actinobacillus pleuropneumoniae (Ap), Mannheimia haemolytica (Mh) and Pasteurella multocida (Pm), is disclosed. Construction of a mutant bacterial strain exclusively expressing the conserved inner core OS epitope as a terminally exposed structure has allowed the identification, production and isolation of an inner core LPS which is common to all three organisms. Further provided are associated vaccines, antibodies raised against the conserved LPS inner core and glycoconjugates comprising the LPS inner core linked to an immunogenic carrier.
机译:公开了在一系列致病性细菌分离株的脂多糖(LPS)上表达的保守的内核寡糖表位,包括胸膜肺炎放线杆菌(Ap),溶血曼海姆氏菌(Mh)和多杀巴斯德氏菌(Pm)。仅将保守的内核OS表位表达为末端暴露结构的突变细菌菌株的构建已允许鉴定,生产和分离所有三种生物共有的内核LPS。还提供了相关疫苗,针对保守的LPS内核的抗体以及包含与免疫原性载体连接的LPS内核的糖缀合物。

著录项

  • 公开/公告号EP1747262B1

    专利类型

  • 公开/公告日2012-09-26

    原文格式PDF

  • 申请/专利权人 NATIONAL RESEARCH COUNCIL OF CANADA;

    申请/专利号EP20050745406

  • 发明设计人 COX ANDREW;RICHARDS JAMES C.;

    申请日2005-05-16

  • 分类号C12N1/20;A61K31/739;C07K16/12;G01N33/569;A61K39/102;A61K39/02;A61P31/04;C12P19/04;A61K47/48;A61K39/116;C08B37;C07H13/04;

  • 国家 EP

  • 入库时间 2022-08-21 17:17:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号